Complainant name: (b)(6).
Age at the time of event: 18 years or older.
Device is a combination product.
Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.
A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.
If there is any further relevant information from that review, a supplemental medwatch will be filed.
(b)(4).
|
(b)(4) clinical study.
It was reported that in-stent restenosis and myocardial infarction occurred.
In (b)(6) 2013, clinical status assessment identified the patient's qualifying condition as silent ischemia.
Prior to procedure, the patient was found to have abnormal stress test or imaging stress test indicative of ischemia and the subject was referred for cardiac catheterization.
Index procedure was performed on the same day.
Target lesion was located in the distal right coronary rca (cass site # 3) with 75% stenosis, and was 23 mm long with a reference vessel diameter of 3 mm.
The target lesion was treated with pre-dilatation, placement of a 3 x 28 mm study stent.
Following post-dilatation the residual stenosis was 0%.
The following day, the patient was discharged on dual antiplatelet therapy.
In (b)(6) 2016, the patient experienced silent myocardial infarction.
The 90% stenosis in the distal rca was treated with placement of drug eluting stent.
Post procedure, the residual stenosis was 0% with timi 3 flow.
|